Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print
This episode isn’t summarized yet
Create a free account and summarize it. In a few minutes you’ll have the key takeaways and a section-by-section summary.
Show notes
Who gets to "play God"? Can old technologies learn new tricks? And what does "drug price" even mean?